Company intelligence / Profile preview

TerraPower

Bellevue, Washington, United States

Ownership: Private
Employees: ~200
Development stage: Other

Overview

TerraPower is constructing its first commercial-scale Natrium advanced nuclear plant in Wyoming (targeting 2030 operation), designed for safer, flexible, carbon-free electricity with integrated energy storage[6][7][8]. Its TerraPower Isotopes division is a leading supplier of Actinium-225 for radiotherapeutics R&D, supporting partners' efforts in clinical oncology[5][3].

Therapeutic areas: Oncology
Modalities: RadiopharmaceuticalRadiotherapeuticIsotope
Industry: Chemicals & Materials

Partnerships

SK Inc / SK Group (strategic investment, commercial collaboration, especially in Asia)[2]Isotek (Thorium-229 recovery for Actinium-225)[5]Ratio Therapeutics (Actinium-225 supply for radiotherapeutic R&D)[3]

Beyond the preview

Go deeper on TerraPower.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on TerraPower.

Explore the full profile